Vaccines 2012 world market analysis, key players, trends, pediatric and adult segments
Upcoming SlideShare
Loading in...5
×
 

Vaccines 2012 world market analysis, key players, trends, pediatric and adult segments

on

  • 440 views

The vaccine industry has seen changes in the past year, and these are covered in this report Vaccines 2012: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry.

The vaccine industry has seen changes in the past year, and these are covered in this report Vaccines 2012: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry.

Statistics

Views

Total Views
440
Views on SlideShare
440
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Vaccines 2012 world market analysis, key players, trends, pediatric and adult segments Vaccines 2012 world market analysis, key players, trends, pediatric and adult segments Document Transcript

    • Vaccines 2012 World Market Analysis, KeyPlayers, Trends, Pediatric and AdultSegmentsThis report examines the market for vaccines used in humans to previous various types of disease. Itcovers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable,such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETECinfection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nilevirus (WNV) infection, etc.; vaccines that address these and other not-yet-vaccine-preventable conditionsare discussed in Kalorama’s new report, “Whats Next in Vaccines.”The vaccine industry has seen changes in the past year, and these are covered in this report Vaccines2012: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry. The highgrowth rates and successful launch of several products recently have kept interest in the global vaccinemarket high. The global market for vaccines experienced strong growth through 2011 and this isexpected to continue through the forecast period. Growth is being fueled by new product introductionsand rising usage in all regions.Get your copy of this report @ http://www.reportsnreports.com/reports/195649-vaccines-2012-world-market-analysis-key-players-trends-pediatric-and-adult-segments.htmlReport Details:Published: September 2012No. of Pages: 249Price: Single User License – US$3995 Corporate User License – US$7990Included in this report are current market size and forecast for the following vaccines:Pediatric Vaccines:  Combinations  Hepatitis  HIB  MMR  Pneumococcal
    •  Poliovirus  Varicella  Other PediatricAdult Vaccines:  Cervical Cancer  Hepatitis  Influenza  Pneumococcal  Travel; DT; Misc.Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccinesales (pediatric and adult segments) in the following regions:  U.S.  Rest of North Amer.  South America  Europe  Japan  India  China  Rest of WorldDespite ongoing improvements in pediatric vaccination, it is estimated that at least two million children dieeach year from diseases that could have been prevented by already existing vaccines. This problem ismost significant in low income countries, with the health disparity between rich and poor countriesresulting in average life spans of about 77 and 52 years, respectively. In addition to this high death toll,millions more suffer disability and illness because they have not been immunized. Adult immunization isan important, but frequently overlooked, part of patient care. Vaccination programs typically focus onchildren, yet adults in industrialized countries are more likely to die as a result of vaccine-preventablediseases than are children.Key issues in the global vaccine market today include product safety, refusal to immunize, supplyshortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations invaccine delivery systems.The following issues are discussed in this report.  Vaccine Safety  Refusal to Immunize
    •  Obesity  Post-Licensure Surveillance  The Future of Vaccine Safety  Vaccine Shortages  Preventing Pandemics  Project Bioshield Act  National Bio and Agro-Defense Facility  DNA Vaccination  Mucosal Delivery  Intranasal Delivery  Vaccine Patches  Vaccine Chips and Microneedles  Innovations in Vaccine Production  Nanoparticle Systems  CloningVaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission.For example, vaccination can prevent about 50% of deaths from pneumococcaldisease and 80% of deaths from influenza-related complications in the elderly. Pharmacoeconomicstudies have demonstrated the value of influenza and pneumococcal vaccines; however, immunizationrates for these diseases continue to be low in the elderly populations. This report includes profiles of thekey players in vaccines, including:  AlphaVax, Inc.  Bavarian Nordic A/S  Baxter Healthcare  Bharat Biotech  Crucell /Johnson & Johnson  Emergent biosolutions  GlaxoSmithKline  Medimmune  Merck & Co. Inc  Novartis  Sanofi Pasteur  Pfizer
    • Explore more reports on Food and Beverage markets @http://www.reportsnreports.com/market-research/food-and-beverages/. Contactsales@reportsandreports.com for further information.Contact:TX, Dallas North - Dominion Plaza,17304, Preston Road,Suite 800, Dallas 75252.+ 1 888 391 5441sales@reportsandreports.comConnect With Us: